MBP metabolic pharmaceuticals limited

metabolic works, page-7

  1. 970 Posts.
    Metabolic would have to license the osteoporosis drug out as they would not have the resources or the facilities to carry out the trial. That’s what they said. The cost is enormous, 10 times what the fat drug cost, because of the protocols that would be needed.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.